The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((5-Bromothiazol-2-yl)methyl)-N-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide ID: ALA4461160
PubChem CID: 155528322
Max Phase: Preclinical
Molecular Formula: C20H18BrN3O4S
Molecular Weight: 476.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)C(=O)c1ccc(N(Cc2ncc(Br)s2)C(=O)c2ccc(O)cc2O)cc1
Standard InChI: InChI=1S/C20H18BrN3O4S/c1-23(2)19(27)12-3-5-13(6-4-12)24(11-18-22-10-17(21)29-18)20(28)15-8-7-14(25)9-16(15)26/h3-10,25-26H,11H2,1-2H3
Standard InChI Key: LYPDEIQDNUKHGB-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
2.7721 -26.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7709 -26.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4790 -27.3827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1886 -26.9733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1858 -26.1506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4772 -25.7453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0643 -25.7458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4788 -28.1999 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8970 -27.3808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8983 -28.1979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6041 -26.9711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3124 -27.3785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0195 -26.9688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6028 -26.1539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3100 -25.7497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3090 -24.9333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6002 -24.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8907 -24.9391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8952 -25.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5978 -23.7078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3043 -23.2971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8889 -23.3012 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0132 -23.7037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3019 -22.4800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7640 -27.2971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3098 -26.6889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9001 -25.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1011 -26.1531 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.2312 -25.2347 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
3 8 1 0
4 9 1 0
9 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
21 24 1 0
13 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 13 1 0
27 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 476.35Molecular Weight (Monoisotopic): 475.0201AlogP: 3.87#Rotatable Bonds: 5Polar Surface Area: 93.97Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.82CX Basic pKa: 1.10CX LogP: 3.01CX LogD: 2.87Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.58Np Likeness Score: -1.24
References 1. Cho H, Shin I, Cho K, Yoon H, Yoon H, Yoo EK, Kim MJ, Park S, Lee IK, Kim ND, Sim T.. (2019) Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors., 62 (18): [PMID:31469962 ] [10.1021/acs.jmedchem.9b00565 ] 2. Morrell, J A JA and 5 more authors. 2003-12 AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2. [PMID:14641019 ] 3. Moore, Jonathan D and 12 more authors. 2014-12-30 VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells. [PMID:25404640 ] 4. Tso, Shih-Chia and 9 more authors. 2017-02-09 Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors. [PMID:28085286 ]